NOT-DA-22-067: Notice of Change to Key Dates for RFA-DA-23-032, "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional)"

Notice of Change to Key Dates for RFA-DA-23-032, "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional)"

Notice Number:

NOT-DA-22-067

Key Dates

Release Date:

August 23, 2022

Related Announcements

RFA-DA-23-032 - NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional)

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This Notice informs applicants of a changes to the Key Dates for Funding Opportunity Announcement (FOA) RFA-DA-23-032, "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional)".

The following Section of RFA-DA-23-032 has been modified to reflect the changed dates:

Currently Reads:

Part 1. Overview Information

Key Dates

Application Due Dates			Review and Award Cycles
New	Renewal / Resubmission / Revision (as allowed)	AIDS	Scientific Merit Review	Advisory Council Review	Earliest Start Date
November 14, 2022	November 14, 2022	Not Applicable	March 2022	May 2022	July 2022
November 14, 2023	November 14, 2023	Not Applicable	March 2023	May 2023	July 2023
November 14, 2024	November 14, 2024	Not Applicable	March 2024	May 2024	July 2024

Expiration Date:

November 15, 2024

Modified to Read (changes shown in bold italics):

Part 1. Overview Information

Key Dates

Application Due Dates			Review and Award Cycles
New	Renewal / Resubmission / Revision (as allowed)	AIDS	Scientific Merit Review	Advisory Council Review	Earliest Start Date
November 14, 2022	November 14, 2022	November 14, 2022	March 2023	May 2023	July 2023
November 14, 2023	November 14, 2023	November 14, 2023	March 2024	May 2024	July 2024
November 14, 2024	November 14, 2024	November 14, 2024	March 2025	May 2025	July 2025

Expiration Date:

November 15, 2024

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Kathy Etz, PhD
Epidemiology Research Branch
National Institute on Drug Abuse (NIDA)
Telephone: 301 402 1749
Email: ketz@nih.gov

Alexa Romberg, PhD
Prevention Research Branch
National Institute on Drug Abuse NIDA)
Telephone: 301-435-0264
Email: alexa.romberg@nih.gov